Gene · 4256
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours. | Pathology | 2024 | 38570266 | PubTator, text mining | PubMed |
| Speeding Up Time: New Urinary Peptide Clock Associates Greater Air Pollution Exposures with Faster Biological Aging. | Environ Health Perspect | 2024 | 38568857 | PubTator, text mining | PubMed |
| Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression. | Life Sci Alliance | 2024 | 38565287 | PubTator, text mining | PubMed |
| Extrahepatic Vitamin K-Dependent Gla-Proteins-Potential Cardiometabolic Biomarkers. | Int J Mol Sci | 2024 | 38542487 | PubTator, text mining | PubMed |
| Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis. | Atherosclerosis | 2024 | 38527383 | PubTator, text mining | PubMed |
| Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment. | Med Oncol | 2024 | 38526604 | PubTator, text mining | PubMed |
| MGP+ and IDO1+ tumor-associated macrophages facilitate immunoresistance in breast cancer revealed by single-cell RNA sequencing. | Int Immunopharmacol | 2024 | 38460300 | PubTator, text mining | PubMed |
| Driving innovation in health care: exploring the impact of ambidextrous leadership on creative performance among frontline health professionals in Norway. | BMC Health Serv Res | 2024 | 38431584 | PubTator, text mining | PubMed |
| Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn's disease. | Scand J Gastroenterol | 2024 | 38411457 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis. | Amyloid | 2024 | 38343068 | PubTator, text mining | PubMed |
| Effect of aging on the human myometrium at single-cell resolution. | Nat Commun | 2024 | 38296945 | PubTator, text mining | PubMed |
| Proteomic analysis of the extracellular matrix of human atherosclerotic plaques shows marked changes between plaque types. | Matrix Biol Plus | 2024 | 38292008 | PubTator, text mining | PubMed |
| EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL. | J Exp Clin Cancer Res | 2024 | 38287371 | PubTator, text mining | PubMed |
| The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta-analysis. | J Nutr Sci | 2024 | 38282652 | PubTator, text mining | PubMed |
| Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. | Genome Med | 2024 | 38281962 | PubTator, text mining | PubMed |
Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol. | BMJ Open | 2024 | 38267238 | PubTator, text mining | PubMed |
| Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights. | Int J Mol Sci | 2024 | 38256228 | PubTator, text mining | PubMed |
| Integrin-associated transcriptional characteristics of circulating tumor cells in breast cancer patients. | PeerJ | 2024 | 38250718 | PubTator, text mining | PubMed |
| Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus. | Cardiovasc Diabetol | 2024 | 38245742 | PubTator, text mining | PubMed |
| Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma. | Heliyon | 2024 | 38223729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4256/papers?page=8